-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Q+A

Scientific Workshop on Mitochondria and Metabolism in Blood Cancer- From Worms to Patients
Program: Scientific Workshops
Session: Mitochondrial and Metabolism - Fundamental Discovery and Model Organisms
Friday, December 8, 2023, 2:10 PM-2:55 PM

Aaron D. Schimmer, MD

Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

Disclosures: Schimmer: UHN: Patents & Royalties: the use of DNT cells to treat AML; Otsuka Pharmaceuticals: Consultancy, Honoraria; Jazz: Consultancy, Honoraria; Novartis: Consultancy, Honoraria; Medivir AB: Research Funding; Takeda Pharmaceuticals: Consultancy, Honoraria, Research Funding; BMS: Research Funding; Medical and Scientific Advisory Board of the Leukemia and Lymphoma Society of Canada: Membership on an entity's Board of Directors or advisory committees.